Embleema

Embleema

Created using Figma

Dernière mise à jour

31 oct. 2018

Vos antécédents médicaux sont inviolables et toujours disponibles grâce aux fonctionnalités de sécurité et de distribution des données Blockchain
Vous choisissez quels prestataires peuvent voir quelle partie de vos antécédents médicaux et vous savez exactement qui y a accédé et quand
Votre vie privée est entièrement protégée de manière conforme à la loi HIPAA
Private Sale
oct., 2018
mars, 2019
100% terminé
Fonds levés - pas de données
309
objectif 20 000 000.00 USD
Casquette 2 000 000.00 USD
Bouchon dur 30 000 000.00 USD
past
  • 1 RWD
    =
    0.2 USD
Détails du jeton
Téléscripteur
RWD
Devises Acceptées
ETH, BTC, BCH, FIAT
Détails de l'entreprise
Nom de l'entreprise enregistrée
Embleema Inc
Pays enregistré
United States, France
Fondation de l'entreprise
Jun 1, 2017
Détails supplémentaires
MVP / Prototype
Oui
Plate-forme
Ethereum
KYC
Oui
Les catégories
Santé

Sur Embleema

Nous croyons que la technologie Blockchain est la norme idéale qui peut fournir aux patients, aux professionnels de la santé, aux payeurs d'assurance-maladie et aux fournisseurs une vision partagée, complète, longitudinale et fiable des antécédents médicaux du patient. Lorsqu'ils sont conservés en tant que registre des transactions, les antécédents médicaux d'un patient sont clairement accessibles à toutes les parties prenantes avec l'autorisation du patient, et la meilleure option de traitement peut être déterminée.

PatientTruth & trade; est une solution logicielle Cloud et Blockchain qui se connecte aux différents dossiers médicaux d'un patient dans les différents centres de soins de santé, tels que les hôpitaux, les cabinets de soins primaires, les centres de réadaptation, les maisons de retraite et les centres de soins urgents. antécédents médicaux complets et inviolables. PatientTruth & trade; fournit une vue holistique des antécédents médicaux d'un patient entre les fournisseurs et les centres de soins.

Caractéristiques

Patients can:

• Register and sign-on through the Patient Dapp interface,

• Upload their health records in the Blockchain, • Visualize their patient record,

• Authorize the sharing of their identified patient record to providers,

• Expose and sell their health records in the Marketplace against RWE tokens,

• Visualize a full audit-trail on their patient record access and health records sold,

• Visualize a statement of his/her RWE transactions.

 

Providers can:

• Register and sign-on through the Provider Dapp interface,

• Visualize an identified patient record, with due consent from the patient,

• Perform a health record quality check, when requested by the health record data owner,

• Visualize a statement of his/her RWE transactions,

 

Care Centers and other Data Owners can:

• Register and sign-on through the Data Owner Dapp interface,

• Have their health records indexed into the Blockchain and linked to patients,

• Expose and sell their health records in the Marketplace against RWE tokens, with due consent from the patients,

• Visualize a statement of RWE transactions,

 

Pharma companies, Payers and other Data Buyers can:

• Register and sign-on through the Data Buyer Dapp interface,

• Expose their inclusion criteria for health record purchases,

• Browse a list of data owners which own health records matching their inclusion criteria,

• Select the data owners they wish to purchase health records from,

• Execute the purchase in RWE tokens with data owners,

• Visualize a statement of RWE transactions,

 

Pharma companies and authorities can:

• Register and sign-on through the Real-World Evidence Dapp interface,

• Pharma companies register health products on which they wish to share with authorities Real-World Evidence, and define the patient records they wish to share,

• Authorities can visualize the shared Real-World Evidence from Pharma companies.

We expect Version 2 to be HIPAA compliant (see “Embleema and Privacy Compliance section” below) for the U.S. users and GDPR compliant for the European users. Version 2 will include health records from U.S. patients. Version 2 is planned to launch in Q3 2019.

Info technique

La Blockchain Embleema Health Version 2 contient les fonctionnalités suivantes:


& bull; Contrats intelligents spécifiques aux soins de santé gérant le consentement du patient,
la conservation des enregistrements de santé, la sauvegarde et le partage des enregistrements du patient (identifiés
et désidentifiés), la piste d'audit d'accès au dossier du patient et le
marché,
& bull; Jeton RWE intégré généré par la chaîne de chaînes pour les frais de transaction
et autres récompenses. Les transactions de jetons RWE ne nécessitent pas de paiement des frais de gaz par l'expéditeur et ont un délai d'extraction prévisible,
& bull; API et analyseurs d’enregistrements d’état de santé à intégrer dans la Blockchain
diverses entrées de format de données pour les enregistrements d’état de santé, telles que HL 7 FHIR,
CCD, formats d’appareils connectés propriétaires et autres formats d’enregistrements de santé,
& bull; Évolutivité: jusqu'à 2 millions de patients pour le marché américain,
& bull; Performances: la visualisation des dossiers médicaux doit avoir lieu en moins de 2 secondes, l'exploitation dans la chaîne de blocs doit durer en moins de 5 secondes,
le rapprochement des acheteurs de données avec les critères d'inclusion des propriétaires de données
dans le Marketplace devrait avoir lieu en moins d'une minute ,
d’autres traitements par lots, tels que l’analyse et l’indexation des sources de données, seront
évalués en termes de performances pour chaque source de données.

Les contrats intelligents exposés au réseau sont les suivants:
& bull; Carnet de santé: écrivez, lisez un carnet de santé dans la Blockchain,
& bull; Dossier patient: connectez les dossiers médicaux à un patient donné, lisez
le dossier patient de la Blockchain,
& bull; Consentement du patient: définit l’autorisation du patient de partager ses
enregistrements de santé (identifiés et désidentifiés),
& bull; Piste d'audit: fournit une piste d'audit des propriétaires de données sur les accès
à leurs dossiers médicaux,
& bull; Place de marché: expose les métadonnées des enregistrements de santé des propriétaires de données
après autorisation des patients, permet aux acheteurs de données de rechercher les enregistrements de santé
à des fins d’achat, et les correspond critères d'inclusion
avec les enregistrements de propriétaires de données, exécute les transactions d'achat
entre les acheteurs de données et les propriétaires de données,
& bull; Contrat intelligent de jetons RWE: émet des jetons RWE en guise de récompense pour les propriétaires de données
qui stockent des enregistrements de santé dans la chaîne de blocs (3 premières années)

% name% roadmap

  • Embleema’s growth plan

  • Embleema has already launched the first patient Blockchain.

    Version 1 is publicly accessible at https://patienttruth.embleema.com
    and contains the following functionalities:
    • Upload HL7 Continuity of Care Documents (CCD) medical records
    into blockchain by patients (U.S. patients only),
    • Upload of Fitbit information into blockchain by patients,
    • Consolidation of CCDs (U.S. patients only) and Fitbit information
    into a Medical history stored securely on blockchain,
    • Authorization management from patients for the sharing of their
    Medical history with providers,
    • Visualization by providers of patients’ Medical histories after due
    authorization from patients,
    • Audit-trail for patients of Medical history accesses by providers,
    • Compensation to patients in EBL tokens for uploading CCDs
    (U.S. patients only) and Fitbit information, as well as referrals of
    new patients and providers.

    Version 1 will be used to pilot and prove in real-life the relevance of
    the 2 key concepts carried by the Embleema Health Blockchain:
    • Patients have control of their health records and may share and
    sell their data to pharma companies: this pilot will start in September
    2018 with cysticfibrosis.com, a U.S. based patient community in
    Cystic Fibrosis (announced on July 17, 2018: https://medcitynews.
    com/2018/07/embleema-emerges-from-stealth-mode-launchesblockchain-
    based-health-record-system/),
    • Pharma companies and regulators share the next generation of
    RWE: real-time, individual-patient level 360 view medical histories,
    with continuous monitoring of the same patient and his/her full
    and trusted consent: this pilot will start in January 2019 with
    a top-5 global pharma company and a leading health regulator
    (announcement planned in Q4 2018).
  • End of 2019

  • End of 2019, Embleema expects to expand its Blockchain to the French
    market and the China marketplace with its 800 million connected patient
    population by striking a set of strategic distribution partnerships with major
    local players in the healthcare and technology industry.
  • Q3 2019

  • Concurrently to its V2 launch in Q3 2019, Embleema plans to set up consulting
    services for pharmaceuticals and health network to facilitate the
    adoption of blockchain in their processes and systems.
  • 2021

  • In 2021, Embleema plans to launch V3 of its Health Blockchain Network
    which will able to integrate mining nodes from pharma companies, payers
    and care centers. V3 will also implement an API allowing third party patient
    app providers to connect to the Blockchain and offer personalized services
    to patients through the Blockchain.
  • Lire la suite
  • 2022

  • For 2022, with a critical mass of patient records stored onto the Blockchain,
    Embleema plans to offer advanced analytics services for various purposes:
    population health, observational studies, safety studies. Embleema will also
    start researching the possibility of offering predictive medicine services
    based on the wealth of data stored in the Blockchain.

Embleema Équipe

Vérifié 100%

Robert Chu
Founder, CEO and CTO
vérifié
Prashant Khambekar,...
Chief Blockchain Development Executive
vérifié
Pradeep Sreekanthan
Chief Delivery Officer
vérifié
Vincent Galand
Manager, Operations
vérifié
Pascal Becache
Business Development Executive
vérifié
Nicolas Schmidt
Chief Product Officer
vérifié
Alexis Normand
Head of Blockchain Consortium
vérifié

Conseillers

Vérifié 29%

Attention. Il y a un risque que les membres non vérifiés ne soient pas réellement membres de l'équipe

Vahan Simonyan, Phd
Advisor | Chief Scientist - WHISE-Embleema Health...
non vérifié
Frederic Duchesne, P...
Advisor | CEO of Pierre Fabre Pharmaceuticals
non vérifié
Atakan Seçkin
Advisor | User Experience
vérifié
Pr. John Halamka, Md
Advisor | Professor of Innovation at Harvard Medic...
non vérifié
Adel Al-Saleh
Advisor | CEO of T-Systems and Board Member of Deu...
non vérifié
Bernard Gilly, Phd
Advisor | CEO at GenSight Biologics & Chairman at...
non vérifié

2 ICO

$12 158 963

Lorenzo Nardiello
Social Media Manager
vérifié

Embleema Entretiens

Atakan Seçkin
As a team member, сan you tell us about your role in the ICO project?
Branding, UI/UX design and implementation of PatientTruth (since POC to product launch) ICO dashboard and future projects
What do you think about idea?
I've designed several products in healthcare industry prior to this project, and none of those projects placed the patient in the center - information asymmetry is a real problem. I believe blockchain with thoughtful design can enable patients to do so much more with their data - not only in terms of being aware, but also the control to choose who can see your data, and monetize it on your own terms and no one else's. We know we have a long road ahead, but I have confidence that we have the best team in the world to be making this product, and we can evolve it in a way that will disrupt existing industries.
Lorenzo Nardiello
As a team member, сan you tell us about your role in the ICO project?
I am in charge of the social media : Telegram, Bitcointalk, Reddit, Discord ... I also organize the bounty program that will come soon and manage our ambassador.
What do you think about idea?
Imagine a world in which you can contribute to medical research and create safer, less expensive and faster new treatments against cancer and rares diseases. Imagine a tamper-proof, holistic, longitudinal and patient-centric worldwide health record interfacing with medical researchers, health regulators, physicians, care centers and the pharmaceutical industry.
Robert Chu
As a team member, сan you tell us about your role in the ICO project?
Founder and CEO of Embleema
I am responsible for overall product strategy, go-to-market and sales of our Embleema Health Blockchain which was launched publicly in July 2018
What do you think about idea?
Embleema Health Blockchain helps patients to advance clinical research by securely sharing their data to pharmaceutical companies during real-world evidence and clinical trial studies. Pharmaceutical companies benefit from faster and more precise data which they can in turn share with regulators such as the U.S. Food and Drug Administration (FDA). Ultimately, patients receive innovative treatments sooner, this is the meaning of our work.
Prashant Khambekar, PhD
As a team member, сan you tell us about your role in the ICO project?
I handle the blockchain development. This includes the ICO/token part.

I also help determine the strategy of the company and its products.
What do you think about idea?
It is a wonderful idea whose time has come. Patients should have the right to control their own health data. The token mechanism helps maintain third-party oversight into the Embleema products.
Pradeep Sreekanthan
As a team member, сan you tell us about your role in the ICO project?
Delivering different versions of the platform. Making the customer experience delightful and easy. Working with various teams.
What do you think about idea?
Revolutionary - bringing healthcare to the blockchain is unusual and will be quite disruptive. RWE in particular.
Vincent Galand
As a team member, сan you tell us about your role in the ICO project?
I am Ops Manager at Embleema Inc. and run Embleema’s ICO operations, coordinating the team of technical experts, legal advisors, social media marketing manager and contractors around the project. I am also developping the business in Europe with pharma companies.
What do you think about idea?
I believe blockchain’s decentralisation power will disrupt the healthcare industry allowing everyone to participate to the advancement of medical progresses. Moreover, we developped a real, concrete industrial use case of Blockchain technology to accelerate medical research, e.g. Real World Evidence / Phase IV clinical trials. We are the only ICO project with a product already available on the market (PatientTruth), first major clients (Pierre Fabre, Servier, others coming soon) and a full support from the medical research community, the pharmaceutical industry and patient associations.
Pascal Becache
As a team member, сan you tell us about your role in the ICO project?
In France and Europe : Investors relations, business development, relations with Pharma companies. As a former IBM and IMS Health executive, I unveil the value of the patient data blockchain for investors, pharmaceutical companies, public and private health insurances and regulators.
What do you think about idea?
Embleema is the future of medical, drugs and population health studies. It will disintermediate collection and use of health data, allowing more, faster, cheaper and more ethical and transparent research benefiting to patients and healthcare systems. It complies with all regulatory aspects in the countries they enter.
Nicolas Schmidt
As a team member, сan you tell us about your role in the ICO project?
I'm Chief Product Officer at Embleema: I lead of our next product development, translate users and customers' needs into a world-class product and manage our marketing.
What do you think about idea?
We're the only healthcare project with a blockchain solution in production, valuable data on usage, several pharma companies as customers and a team of world-class advisors. We achieved all of this before launching our ICO in order to reduce risks for potential subscribers.
Alexis Normand
As a team member, сan you tell us about your role in the ICO project?
I bring together patient advocacy groups & life sciences researchers and regulatoirs to create a decentralized marketplace for health data, to replace the slow, manual and costly process of collecting real world evidence (RWE) for late stage clinical research
What do you think about idea?
Allowing patients to opt-in to pharma research along their own terms is game changing. Only blockchain allows patients to assemble the full picture of their health data, own and share it, and be compensated for their active involvement in clinical research.

Embleema Dernières nouvelles

  • En raison des différences temporelles dans les mises à jour des informations, des informations précises sur chaque projet ICO doivent être vérifiées sur son site web officiel ou via un autre canal de communication.
  • Cette information n'est pas une suggestion ou un conseil pour investir dans un financement ICO. Veuillez examiner vous-même les informations pertinentes et décider de la participation de l’OIC.
  • Si vous pensez que des problèmes ou des problèmes doivent être résolus concernant ce contenu, ou si vous souhaitez soumettre votre propre projet ICO pour figurer dans la liste, veuillez nous envoyer un courrier électronique.
Veuillez lire la clause de non-responsabilité et l'avertissement de risque. Afficher l'avertissement et l'avertissement de risque.